Andreas Obermair
Overview
Explore the profile of Andreas Obermair including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
179
Citations
2810
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Obermair A, Gebski V, Goh J, Kuchel A, Brand A, Mak B, et al.
Int J Gynecol Cancer
. 2025 Feb;
:101644.
PMID: 39955187
Background: The standard treatment for endometrial cancer is hysterectomy with or without bilateral salpingo-oophorectomy; however, this may not be an optimal choice for women who have not completed childbearing or...
2.
Tuesley K, Spilsbury K, Pearson S, Donovan P, Obermair A, Coory M, et al.
J Natl Cancer Inst
. 2025 Jan;
PMID: 39805314
Background: Use of long-acting, reversible contraceptives has increased over the past 20 years, but an understanding of how they could influence cancer risk is limited. Methods: We conducted a nested...
3.
Plinsinga M, Rye S, Jones T, Vagenas D, Ward L, Janda M, et al.
Gynecol Oncol
. 2024 Oct;
191:158-164.
PMID: 39423553
Objectives: To describe lower-limb symptoms pre- through to 2-years post-surgery following newly diagnosed gynecological cancer; to explore relationships between lower-limb symptoms, lower-limb lymphedema, body image, quality of life, anxiety and...
4.
Ng Z, Manchanda R, Lopez A, Obermair A, Dostalek L, Pareja R, et al.
Gynecol Oncol
. 2024 Oct;
191:95-99.
PMID: 39378742
Objective: Patients with TNM T1a cervical cancer have excellent prognosis; however, the risk for recurrence remains an issue of concern and management guidelines are based on limited data. Here we...
5.
Virili F, Obermair A, Sanjida S, Nicklin J, Garrett A, Land R, et al.
Int J Gynecol Cancer
. 2024 Sep;
PMID: 39237158
Objective: Imaging for staging ovarian cancer is important to determine the extent of disease. The primary objective of this study was to compare gated 18F-fluorodeoxyglucose positron emission tomography coupled with...
6.
Na R, Jordan S, DeFazio A, Williams M, Livingstone K, Obermair A, et al.
Int J Cancer
. 2024 Sep;
156(2):280-292.
PMID: 39222307
Menopausal hormone therapy (MHT) use before ovarian cancer diagnosis has been associated with improved survival but whether the association varies by type and duration of use is inconclusive; data on...
7.
Collings R, Potter C, Gebski V, Janda M, Obermair A
Am J Obstet Gynecol
. 2024 Aug;
232(1):104.e1-104.e12.
PMID: 39111518
Background: Obstetrics and gynecology surgery is becoming increasingly complex because of an aging population with increasing rates of medical comorbidities and obesity. Complications are therefore common, and not only impact...
8.
Somasegar S, Anastasio M, Karam A, Rossi E, Obermair A
Am Soc Clin Oncol Educ Book
. 2024 May;
44(3):e438550.
PMID: 38815208
Cancer outcomes are largely measured in terms of disease-free survival or overall survival, which is highly dependent on timely diagnosis and access to treatment methods available within the country's existing...
9.
Ramirez P, Robledo K, Frumovitz M, Pareja R, Ribeiro R, Lopez A, et al.
J Clin Oncol
. 2024 May;
42(23):2741-2746.
PMID: 38810208
JCO The aim of this study was to compare overall survival between open and minimally invasive radical hysterectomy with participants followed for 4.5 years. The primary objective was to evaluate...
10.
Ribeiro R, Baiocchi G, Obermair A, Costa C, Leitao M
Int J Gynecol Cancer
. 2024 Mar;
34(3):403-408.
PMID: 38438174
Objective: To review rates of uterine preservation and gonadal function, surgical outcomes, and pregnancy outcomes in patients undergoing surgical uterine transposition. Methods: A structured search and analysis of the published...